-
公开(公告)号：US20240368297A1
公开(公告)日：2024-11-07
申请号：US18633939
申请日：2024-04-12
Applicant: Genmab A/S
Inventor： Tommy R. LI , Craig J. THALHAUSER
IPC: C07K16/28 , A61K31/138 , A61K31/573 , A61K39/00 , A61P35/00
Abstract: The present invention provides dosing regimens of bispecific antibodies targeting both CD3 and CD20 when used in the treatment of lymphoma, such as B-cell Non-Hodgkin lymphoma (B-NHL).
Search Results
1
records
(took 0.023 seconds)
筛选
AND
AND
过滤
NOT
NOT
Scan to Join
